Pharma Mar SA (PHMR.MC)
23 Mar 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|President, Chief Executive Officer, Executive Chairman of the Board|
|Executive Vice Chairman|
|Chief Financial Officer|
|Director of Human Resources and IT|
|2011||Vice President - Medical Affairs|
- BRIEF-Pharma Mar FY Net Loss Widens To 26.7 Mln Euros YoY
- BRIEF-Pharma Mar Announces Positive Results Of Its MI13004 Antibody Conjugate
- BRIEF-Pharma Mar Licenses Marine-Derived Payloads To Seattle Genetics
- BRIEF-Pharma Mar Says Phase III Trial With Zepsyre In Resistant Ovarian Cancer Not Met Its Primary Endpoint
- BRIEF-Pharma Mar Requests Re-Examination Process For Aplidin From EMA